Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 0.29 + web + 26,500  Related to the article below (Last Update: 8/4/2008)

Sovereign Bancorp, Inc. Announces Second Quarter 2008 Results
MSN Money - Jul 23, 2008
Investors, analysts and other interested parties will have the opportunity to listen to a live web-cast of Sovereign's Second Quarter 2008 earnings call on ...SOV
Source: Google News

[PDF] … Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial Food Web of the Kalamazoo … -
AL Blankenship, MJ Zwiernik, KK Coady, DP Kay, JL … - Environmental Science & Technology, 2005 - msu.edu
Differential Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial
Food Web of the ... This study focused on two locations for food web analysis. ...

Renewable Hydrogen from Ethanol by Autothermal Reforming -
GA Deluga, JR Salge, LD Schmidt, XE Verykios - Science, 2004 - sciencemag.org
... 117 article(s) on the ISI Web of Science. ... of Chemical Engineering, University of
Patras, GR-26500 Patras Greece ... 1, and a ratio of 0.29 corresponds to combustion ...

[PDF] The energy of the ions bombarding the vacuum chamber walls -
O Malyshev - Vacuum Technical Note, 1999 - lhc-div-vac.web.cern.ch
... H 2 + CO + H 2 + CO + IP1 50-80 0.5 0.022 13600(26500) 2700 (7850) 7500 (15500)
1300 (3750) Inner triplet Q1 ... 178 0.29 240 (353) 224 (242) 153 (198) 147 (159) ...

Dramatic Effects of the Substituents on the Solid-state Fluorescence Properties of Structural … -
Y Ooyama, Y Harima - Chemistry Letters, 2006 - J-STAGE
... 21200) 515, 482 0.99 11 416(14500), 355(26500) 1,4 ... E 1=2 ) of these compounds are
0.29?0.33, 0.80 ... Published on the web (Advance View) July 8, 2006; doi:10.1246 ...

SPECTROSCOPY AND PHOTOMETRY OF STELLAR OBJECTS FROM THE SECOND BYURAKAN SURVEY1 JA STEPANIAN, 2 RF …
JA STEPANIAN - THE ASTRONOMICAL JOURNAL, 2001 - iop.org
Page 1. THE ASTRONOMICAL JOURNAL, 122:3361?3382, 2001 December ( 2001. The American
Astronomical Society. All rights reserved. Printed in USA ...
-

FINAL REPORT ON THE QUALITY CONTROL OF TRACE METAL ANALYSIS FOR THE MAFLA BASELINE ENVIRONMENTAL …
A PRECISE-ACCURATE - gomr.mms.gov
... PO Box 26500 . ... organisms important in the biological food web, zooplankton and benthic
invertebrates . ... ranging from 0.29 ppb (PAD-87) to 1.03ppb (PAD7) . ...
-

Nutritional value of trace elements in spaghetti sauces and their classification according to the … -
GD Kanias, S Ghitakou, H Papaefthymiou - Journal of Radioanalytical and Nuclear Chemistry, 2006 - Springer
... and Nuclear Chemistry, Department of Chemistry, University of Patras, Patra 26500,
Greece (Received ... In relation to zinc data our values (0.13 mg?0.29 mg per ...

[PDF] Molecular Simulation of Phase Equilibria for Water-Methane and Water-Ethane Mixtures -
JR Errington, GC Boulougouris, IG Economou, AZ … - J. Phys. Chem. B, 1998 - chemical.buffalo.edu
... V ersity of Patras, GR-26500 Patras, Greece ... 10.1021/jp981627v CCC: $15.00 ? 1998
American Chemical Society Published on Web 10/13/1998 Page 2. ...
-

Bipyridyl oxadiazoles as efficient and durable electron-transporting and hole-blocking molecular … -
M Ichikawa, T Kawaguchi, K Kobayashi, T Miki, K … - Journal of Materials Chemistry, 2006 - rsc.org
... First published on the web 4th November 2005. ... Then, 0.29 g of isophthaloyl dichloride
was added slowly and refluxed ... Bpy-OXDpy (30 nm), 2.7, 26500, at 10 V, 6.7, 2.5 ...

[PDF] Engineering a molecular model for water phase equilibrium over a wide temperature range -
GC Boulougouris, IG Economou, DN Theodorou - J. Phys. Chem. B, 1998 - mmml.chem.demokritos.gr
... Engineering, Uni V ersity of Patras, GR 26500 Patras, Greece, and Department of ...
97)02582-0 CCC: $15.00 ? 1998 American Chemical Society Published on Web 01/22 ...
-

Source: Google Scholar
 
 

Sibutramine shouldn't be used in combination with SSRI antidepressants due to a possible risk of serotonin syndrome

 
 
Sibutramine ( Meridia/Reductil ) is a noradrenaline and serotonin reuptake inhibitor indicated for weight loss. It has been available in Australia since January 2002 but is not funded by the PBS ( Pharmaceutical Benefit Scheme ).

To date, ADRAC ( Adverse Drug Reactions Advisory Committee ) has received 138 reports ( 404 adverse reactions ) associated with the use of Sibutramine.

The common adverse reactions reported are consistent with the product information and are listed as follows: nervous system 62 ( headache 20, dizziness 14, serotonin syndrome 5 ), psychiatric 50 ( depression 12, anxiety 11, insomnia 10, aggression 6, agitation 6 ), gastrointestinal 33 ( nausea 9, constipation 6, dry mouth 6 ), cardiac 31 ( rhythm disorders 11, palpitations 9, chest pain 4 ), vascular 26 ( hypertension 8 ), respiratory 15 ( dyspnoea 11 ).

Psychiatric reactions have been reported at both extremes of the spectrum, specifically depression and mania. Sibutramine was the sole suspected medicine in 11 of the 12 cases of depression. The time to onset was relatively short, ranging from 1 to 13 days. Most patients ( 11 ) recovered after stopping Sibutramine. The 12 reports included 2 of suicidal ideation and 2 of suicide Sibutramine was the sole suspected medicine in 2 of the 3 reports of mania. Both of these patients recovered after ceasing Sibutramine. The other manic event occurred in a patient with a history of previously well controlled bipolar disorder.

Reported cardiovascular adverse reactions have included cardiac rhythm disorders, palpitations and chest pain. Sibutramine was the sole suspected medicine in 27 cases. The two most serious adverse reactions were ventricular fibrillation with cardiac arrest and myocardial infarction. There have also been 8 reports of hypertension.

Serotonin syndrome was reported in 5 cases, with time to onset ranging from 1 to 22 days. Sibutramine was used with Tramadol in 2 cases, with Sertraline in 1 case and was the sole medication in the other 2 cases.

Sibutramine should not be used in combination with other CNS-active drugs, such as MAOIs and SSRIs, due to a possible interaction and the risk of serotonin syndrome. Sibutramine is not recommended for use in patients with a history of heart disease as it tends to increase heart rate and blood pressure.

Source: Australian Adverse Drug Reactions Bulletin, 2006
 
 
 
Google
Web www.iconocast.com
 
 
 

 

ALL THE NEWS : News1 ; News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page